Verrica Pharmaceuticals Inc
VRCA7.820USD
-0.290-3.58%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
74.21MMarket Cap
LossP/E TTM
Verrica Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
7.57M
47.66%
EPS(YoY)
-14.78
-0.04%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 7.57M, with a year-on-year change of 47.66%.
What is the Earnings Per Share (EPS) of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -14.781, with a year-on-year change of -0.04%.
What is the net income of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its net income was -76.58M, with a year-on-year change of -14.31%.
What is the net margin of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -1012.15%, with a year-on-year change of 22.59%.
What is the gross margin of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 63.79%, with a year-on-year change of -25.35%.
What is the debt-to-asset ratio of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 83.20%, with a year-on-year change of 53.34%.
What is the Return on Equity (ROE) of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -1546.58%, with a year-on-year change of -590.20%.
What is the Return on Assets (ROA) of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -112.84%, with a year-on-year change of -6.38%.
What is the operating profit of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -65.84M, with a year-on-year change of -4.13%.
What are the current assets of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its current assets were 51.18M, with a year-on-year change of -33.99%.
What are the total assets of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its total assets of Verrica Pharmaceuticals Inc were 54.13M, with a year-on-year change of -33.66%.
What are the total liabilities of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Verrica Pharmaceuticals Inc were 63.99M, with a year-on-year change of 3.49%.
What is the total equity of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its total equity of Verrica Pharmaceuticals Inc was -9.86M, with a year-on-year change of -149.89%.
What is the net operating income of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Verrica Pharmaceuticals Inc was -76.58M, with a year-on-year change of -14.31%.
What is the net investment of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its net investment of Verrica Pharmaceuticals Inc was -19.00K, with a year-on-year change of 94.75%.
What is the net financing of Verrica Pharmaceuticals Inc?
According to Verrica Pharmaceuticals Inc's FY2024 earnings report, its net financing of Verrica Pharmaceuticals Inc was 37.73M, with a year-on-year change of -49.16%.
